Rectal Cancer (MSK, Nature Medicine 2022)

Summary

Rectal Cancer (MSK, Nature Medicine 2022) is a study catalogued by cBioPortal DataHub under the cancer-type code bowel. EvidenceHelix groups it with colorectal studies.

Study description

DNA and RNA sequencing of 738 primary rectal tumors.

Text as published in the source's study metadata.

Citation & PubMed

Walid K et al. Nature Medicine 2022

Linked PubMed records: PMID 35970919

Source & licence

Metadata from cBioPortal DataHub at e1b75cd25b, available under the ODC Open Database License (ODbL) 1.0. See the Source metadata tab for every field.

Source metadata

Study identifier

rectal_msk_2022

Short name

not given

Source cancer-type code

bowel

Reference genome

not given

Source access groups

not given

Original study

View on cBioPortal

Metadata file

meta_study.txt at e1b75cd25b

Database licence

ODC Open Database License (ODbL) 1.0

Study-level metadata only (title, description, cancer-type code, citation, PubMed ids). No patient, sample, mutation or clinical data, and no publication full text, is included. Individual studies may carry their own terms; follow each study's source links before reusing its data.

Citations

Walid K et al. Nature Medicine 2022

• PubMed record 35970919 ↗

Citation counts are not part of the source metadata and are not shown.

Related studies

• Colorectal Adenocarcinoma (MSK, Nat Commun 2022)

  Targeted sequencing of 180 colitis-associated cancers and their matched normals.

  ColorectalMSK studiesSource code bowelPubMed 1

• Colorectal Cancer (MSK, JNCI 2021)

  Targeted sequencing of 1,516 samples from 818 patients with early onset and 698 patients with average onset colorectal cancer and their matched normals.

  ColorectalMSK studiesSource code bowelPubMed 1

• Colorectal Adenocarcinoma (DFCI/Orion, BioRxiv 2024)

  Combined spatial and targeted genomic analysis of 74 colon and rectal cancers.

  ColorectalOther published and consortium studiesSource code bowelPubMed 1

• Colorectal Adenocarcinoma Triplets (MSK, Genome Biol 2014)

  Targeted sequencing of primary, metastatic, and normal tissues from 69 colorectal adenocarcinoma patients.

  ColorectalMSK studiesSource code coadreadPubMed 1

• Colorectal Cancer (HTAN MSK, Nature 2025)

  Targeted genomic and single-cell RNA sequencing of normal colon, primary colorectal cancer, and matched metastatic samples from 29 patients.

  ColorectalMSK studiesSource code coadreadPubMed 1

• Colorectal Cancer (MSK, Cancer Discovery 2022)

  Targeted sequencing of patient-derived xenografts, cell lines, tumors and their matched normals from 22 colorectal samples via MSK-IMPACT.

  ColorectalMSK studiesSource code coadreadPubMed 1

• Colorectal Cancer (MSK, Gastroenterology 2020)

  Targeted sequencing of 471 unresectable colorectal tumor/normal pairs via MSK-IMPACT.

  ColorectalMSK studiesSource code coadreadPubMed 1

• Colorectal Cancer (MSK, JCO Precis Oncol 2022)

  Molecular characterization of 47 BRAF inhibitor-naive colorectal cancer patients with dual RAS hotspot/BRAF V600E mutations.

  ColorectalMSK studiesSource code coadreadPubMed 1

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.